Loading...

Livzon Pharmaceutical Group Inc.

LVZPF•PNK
Healthcare
Drug Manufacturers - Specialty & Generic
$3.43
$0.00(0.00%)

Livzon Pharmaceutical Group Inc. (LVZPF) Stock Overview

Explore Livzon Pharmaceutical Group Inc.’s financial performance, market position, analyst ratings, and future outlook.

Meyka AI Score

F

Score: N/A

Key Financials

Market Cap4B
P/E Ratio10.52
EPS (TTM)$0.30
ROE0.15%
Fundamental Analysis

AI Price Forecasts

1 Week$3.43
1 Month$3.45
3 Months$3.69
1 Year Target$3.69

LVZPF Stock Analysis & Investment Overview

Our comprehensive AI-powered analysis of Livzon Pharmaceutical Group Inc. (LVZPF) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of F, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.

The current technical analysis reveals key indicators including an RSI of 48.15, suggesting the stock is in a neutral condition. Our forecasting models predict significant price movements, with a 12-month target of $3.69.

Key financial metrics showcase the company's fundamental strength, including a P/E ratio of 10.52 and a market capitalization of 4B. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.

1-Day Change
N/A
5-Day Change
N/A
1-Month Change
N/A
3-Month Change
N/A
6-Month Change
-5.51%
Year-to-Date (YTD) Change
N/A
1-Year Change
10.29%
3-Year Change
-2.56%
5-Year Change
-7.30%
All-Time (Max) Change
-25.76%

Contact Information

https://www.livzon.com.cn
86 75 6813 5888
Headquarters Building, Zhuhai, 519090

Company Facts

9,067 Employees
IPO DateJun 29, 2018
CountryCN
Actively Trading

Frequently Asked Questions

;